Arbutus Biopharma Corp·4

Jan 20, 5:54 PM ET

Picchio Gaston 4

4 · Arbutus Biopharma Corp · Filed Jan 20, 2022

Insider Transaction Report

Form 4
Period: 2022-01-20
Picchio Gaston
Chief Development Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-01-20$2.81/sh+256,500$720,765256,500 total
    Exercise: $2.81Exp: 2032-01-20Common Shares (256,500 underlying)
Footnotes (1)
  • [F1]These stock options will vest and become exercisable 1/48th each month over the four year period.

Documents

2 files
  • 4
    wf-form4_164271923431244.xmlPrimary

    FORM 4

  • EX-24

    POA - PICCHIO